HOPEWELL, N.J., Jul 1, 2026 /PRNewswire/ -- The University of California, Irvine (UC Irvine) School of Medicine and GlyTR Therapeutics have developed a next‑generation AAV‑mediated CAR T‑cell platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results